Literature DB >> 12151381

Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin.

Ke Ma1, Agatha Cabrero, Pradip K Saha, Hideto Kojima, Lan Li, Benny Hung-Junn Chang, Antoni Paul, Lawrence Chan.   

Abstract

Previous reports showed that recombinant fragments of adiponectin (adipo) displayed pharmacological effects when injected into rodents, but the relevance of these observations to the physiological function of adipo is unclear. We generated Adipo(-/-) mice by gene targeting. Adipo(-/-) mice are fertile with normal body and fat pad weights. Plasma glucose and insulin levels of Adipo(-/-) and Adipo(+/+) mice are similar under fasting conditions and during an intraperitoneal glucose tolerance test (GTT). Insulin tolerance test (ITT) also produces similar plasma glucose and insulin levels in the two groups of mice. Hyperinsulinemic-euglycemic clamp analysis showed that Adipo(-/-) and Adipo(+/+) mice have similar glucose infusion rates to maintain a similar serum glucose. High-fat diet feeding for 7 months led to similar weight gain and similar GTT and ITT responses. We next measured beta-oxidation and found it to be significantly increased in muscle and liver of Adipo(-/-) mice. In conclusion, our study indicates that absence of adipo causes increased beta-oxidation but does not cause glucose intolerance or insulin resistance in mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151381     DOI: 10.1074/jbc.C200362200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  110 in total

Review 1.  Tissue-specific targeting of the insulin receptor gene.

Authors:  Rohit N Kulkarni; Terumasa Okada
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 2.  Regulation of adipocytokines and insulin resistance.

Authors:  M Fasshauer; R Paschke
Journal:  Diabetologia       Date:  2003-11-06       Impact factor: 10.122

3.  C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway.

Authors:  Qijun Zheng; Yuexing Yuan; Wei Yi; Wayne Bond Lau; Yajing Wang; Xiaoliang Wang; Yang Sun; Bernard L Lopez; Theodore A Christopher; Jonathan M Peterson; G William Wong; Shiqiang Yu; Dinghua Yi; Xin-Liang Ma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

4.  Adiponectin is sufficient, but not required, for exercise-induced increases in the expression of skeletal muscle mitochondrial enzymes.

Authors:  Ian R W Ritchie; Tara L MacDonald; David C Wright; David J Dyck
Journal:  J Physiol       Date:  2014-03-31       Impact factor: 5.182

Review 5.  Adipocytes as regulators of energy balance and glucose homeostasis.

Authors:  Evan D Rosen; Bruce M Spiegelman
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 6.  Adipocyte-derived hormones, cytokines, and mediators.

Authors:  Cristina M Rondinone
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

7.  Elevated adiponectin expression promotes adipose tissue vascularity under conditions of diet-induced obesity.

Authors:  Tamar R Aprahamian
Journal:  Metabolism       Date:  2013-08-28       Impact factor: 8.694

Review 8.  Implications of adiponectin in linking metabolism to testicular function.

Authors:  Luc J Martin
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

Review 9.  Adiponectin, driver or passenger on the road to insulin sensitivity?

Authors:  Risheng Ye; Philipp E Scherer
Journal:  Mol Metab       Date:  2013-04-19       Impact factor: 7.422

10.  Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice.

Authors:  Maria Pini; Melissa E Gove; Joseph A Sennello; Jantine W P M van Baal; Lawrence Chan; Giamila Fantuzzi
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.